SCHEMBL16387865

SCHEMBL16387865

O=C(N[C@H]1CC[C@@H](CO)C1)C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PKM P14618 1/20 0.46
▸ DRD2 P14416 6/20 0.36
▸ HTR2A P28223 6/20 0.36
▸ DRD3 P35462 6/20 0.36
▸ CA2 P00918 1/20 0.35
▸ HTR1A P08908 1/20 0.35
▸ PTGES O14684 4/20 0.34
▸ PDK1 Q15118 1/20 0.34
▸ PDK2 Q15119 1/20 0.34
▸ PDK3 Q15120 1/20 0.34
▸ PDK4 Q16654 1/20 0.34
▸ PDE7A Q13946 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ ASGR1 P07306 1/20 0.32
▸ LRRK2 Q5S007 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ POLB P06746 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14840942 0.89 PKM (0.48) PKMDRD2HTR2ADRD3CA2
SCHEMBL14840943 0.89 PKM (0.48) PKMDRD2HTR2ADRD3CA2
SCHEMBL993860 0.78 PKM (0.61) PKMDRD2HTR2ADRD3CA2
SCHEMBL15663103 0.77 PDE7A (0.38) PKMPTGESPDE7AKMT2APOLB
SCHEMBL31662032 0.77 PDE7A (0.38) PKMPTGESPDE7AKMT2APOLB
SCHEMBL3644237 0.77 PDE7A (0.38) PKMPTGESPDE7AKMT2APOLB
SCHEMBL26906160 0.77 PDE7A (0.38) PKMPTGESPDE7AKMT2APOLB
SCHEMBL14828555 0.77 PDE7A (0.38) PKMPTGESPDE7AKMT2APOLB
SCHEMBL21069559 0.77 PDE7A (0.38) PKMPTGESPDE7AKMT2APOLB
SCHEMBL3646438 0.77 PDE7A (0.38) PKMPTGESPDE7AKMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015002994-A2 HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME MILLENNIUM PHARMACEUTICALS, INC. (US) 2015-01-08 — — WO disclosed
Send feedback